MNEX Invests P180 Million in Batangas Components Plant

Singapore-based manufacturer MNEX is investing P180 million in a plant in Batangas, according to Newsbytes. The facility is planned to produce precision-molded components for consumer electronics, medical devices and industrial products.

Newsbytes reported that production at the Batangas plant is targeted to begin in early 2027. The investment places medical device components within the facility’s stated manufacturing scope alongside electronics and industrial products.

Batangas plant planned for precision-molded components

Newsbytes identified MNEX as a Singapore-based manufacturer and reported that its Batangas facility will make precision-molded components. Medical devices are among the product categories named in the report.

The reported project is centered on component manufacturing rather than a finished-device announcement. Newsbytes said the plant’s planned output also includes components for consumer electronics and industrial products.

Production target set for early 2027

Newsbytes reported that MNEX is targeting early 2027 for the start of production. The P180 million investment and the early-2027 production target are the milestones disclosed for the Batangas project.

For medical device sales professionals, the announcement concerns a planned manufacturing site for precision-molded components used across the medical device, consumer electronics and industrial product categories. Newsbytes did not include further details on the plant’s medical-device component programs.

Reported project details

• Company: MNEX
• Location: Batangas
• Investment: P180 million
• Planned output: Precision-molded components for consumer electronics, medical devices and industrial products
• Production target: Early 2027

Newsbytes reported the investment as a Batangas manufacturing initiative with planned production spanning three stated product areas. The report identified precision molding as the facility’s intended component-production focus.